T. Rowe Price Investment Management, Inc.
Position in TXG — 10x Genomics, Inc.
CIK 1897612
BALTIMORE, MD
Position in TXG
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,161,279
+$6,292,586 QoQ
Shares Held
1,279,382
-0.0% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
11 quarters on record
Voting authority
Sole 99.20086416723073.ToString("F0")%
Shared 0.ToString("F0")%
None 0.7991358327692589.ToString("F0")%
Common Shares in TXG Over Time
Shares Held
Position Value (USD)
Position in Health Information Services
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $958,090,518 across 4 Health Information Services names. TXG ranks #3 (2.8% of the industry book) .
All Filings in TXG
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,161,279 | 1,279,382 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,868,693 | 1,279,503 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $15,692,924 | 1,342,423 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,321,592 | 977,685 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $48,812,879 | 2,161,775 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,069,941 | 2,162,979 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $82,732,257 | 2,204,430 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $63,852,822 | 1,141,044 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $41,112,431 | 996,665 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $55,653,773 | 996,665 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $57,238,364 | 1,025,961 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||